ConductScience.org, home

Trial · NCT00772031

Results by group18

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Change in the Number of Moderate to Severe Headache Days Within a 28 Day Average Period in Six Months Compared to BaselineTopiramate Plus Propranolol4.4Standard Deviation 5.98Moderate to severe headache days
Change in the Number of Moderate to Severe Headache Days Within a 28 Day Average Period in Six Months Compared to BaselineTopiramate Plus Placebo4.7Standard Deviation 5.66Moderate to severe headache days
Number of Subjects Experiencing at Least a 30% Reduction in 28-day Moderate to Severe Headache DaysTopiramate Plus Proporanolol37participants
Number of Subjects Experiencing at Least a 30% Reduction in 28-day Moderate to Severe Headache DaysTopiramate Plus Placebo28participants
Number of Subjects Experiencing at Least a 50% Reduction in 28-day Moderate to Severe Headache DaysTopiramate Plus Propranolol26participants
Number of Subjects Experiencing at Least a 50% Reduction in 28-day Moderate to Severe Headache DaysTopiramate Plus Placebo23participants
Change From Baseline in Beck's Depression Inventory FastScreen Score at 6 MonthsTopiramate Plus Propranolol0.3Standard Deviation 0.25units on a scale
Change From Baseline in Beck's Depression Inventory FastScreen Score at 6 MonthsTopiramate Plus Placebo0.6Standard Deviation 0.30units on a scale
Change From Baseline in Migraine Disability Assessment (MIDAS) Score at 6 MonthsTopiramate Plus Propranolol-3.18Standard Deviation 3.70units on a scale
Change From Baseline in Migraine Disability Assessment (MIDAS) Score at 6 MonthsTopiramate Plus Placebo-3.46Standard Deviation 3.82units on a scale
Change From Baseline in Migraine Specific Quality of Life (MSQ)-Role Restrictive Score at 6 MonthsTopiramate Plus Propranolol-0.7Standard Deviation 5.5units on a scale
Change From Baseline in Migraine Specific Quality of Life (MSQ)-Role Restrictive Score at 6 MonthsTopiramate Plus Placebo-2.2Standard Deviation 5.71units on a scale
Change From Baseline in Migraine-Specific Quality of Life (MSQ)-Role Preventive at 6 MonthsTopiramate Plus Propranolol, no Prior, Stable Topiramate12.9Standard Deviation 2.88units on a scale
Change From Baseline in Migraine-Specific Quality of Life (MSQ)-Role Preventive at 6 MonthsTopiramate Plus Placebo, no Prior, Stable Topiramate5.9Standard Deviation 3.10units on a scale
Change From Baseline in Migraine-Specific Quality of Life (MSQ)-Role Preventive at 6 MonthsTopiramate Plus Propranolol, Prior, Stable Topiramate-11.5Standard Deviation 5.00units on a scale
Change From Baseline in Migraine-Specific Quality of Life (MSQ)-Role Preventive at 6 MonthsTopiramate Plus Placebo, Prior, Stable Topiramate11.0Standard Deviation 5.06units on a scale
Change From Baseline in Migraine-Specific Quality of Life (MSQ) - Emotional Function at 6 MonthsTopiramate Plus Propranolol8.9Standard Deviation 3.43units on a scale
Change From Baseline in Migraine-Specific Quality of Life (MSQ) - Emotional Function at 6 MonthsTopiramate Plus Placebo9.8Standard Deviation 3.80units on a scale

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00772031/results